Although ALK gene fusions are known to trigger both the humoral and CTL responses in ALCL patients, there are recent reports showing that ALK fusions can also induce the expressions of an important immune checkpoint protein, programmed cell death 1 (PD-L1). This evidence concerns the gene PDCD1 and anaplastic large cell lymphoma.